Omeros (OMER) Revenue Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.03% |
| Sep 30, 2021 | 21.59% |
| Jun 30, 2021 | 23.57% |
| Mar 31, 2021 | 23.20% |
| Dec 31, 2020 | 9.76% |
| Sep 30, 2020 | 51.62% |
| Jun 30, 2020 | 33.53% |
| Mar 31, 2020 | 127.29% |
| Dec 31, 2019 | 184.28% |
| Sep 30, 2019 | 168.49% |
| Jun 30, 2019 | 258.78% |
| Mar 31, 2019 | 193.50% |
| Dec 31, 2018 | 164.83% |
| Sep 30, 2018 | 88.04% |
| Jun 30, 2018 | 63.88% |
| Mar 31, 2018 | 7.72% |
| Dec 31, 2017 | 54.11% |
| Sep 30, 2017 | 72.52% |
| Jun 30, 2017 | 62.24% |
| Mar 31, 2017 | 52.30% |
| Dec 31, 2016 | 62.38% |
| Sep 30, 2016 | 62.80% |
| Jun 30, 2016 | 54.00% |
| Mar 31, 2016 | 43.04% |
| Dec 31, 2015 | 46.89% |
| Sep 30, 2015 | 66.59% |
| Jun 30, 2015 | 45.01% |